Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretion
- 1 July 2014
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 107, 6-15
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Potent inhibition of human Hepatitis B virus replication by a host factor Vps4Virology, 2006
- Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virusAntiviral Research, 2006
- Envelopment of the hepatitis B virus nucleocapsidVirus Research, 2004
- Iminosugars as Possible Broad Spectrum anti Hepatitis Virus Agents: The Glucovirs and AlkovirsAntiviral Chemistry and Chemotherapy, 2001
- Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and traffickingNature Medicine, 1998
- Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin.Proceedings of the National Academy of Sciences, 1994
- Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic miceCell, 1989
- Identification of the Metabolites of an Antiallergic Agent, 1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1, 4-diazepin-1-yl)-1H-benzimidazole Difumarate (KG-2413), in RatsYAKUGAKU ZASSHI, 1989
- Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cellsGene, 1988
- Heterocyclic quinones with potential antitumor activity. 2. Synthesis and antitumor activity of some benzimidazole-4,7-dione derivativesJournal of Medicinal Chemistry, 1988